Joseph E. Sokal
#135,182
Most Influential Person Now
Joseph E. Sokal's AcademicInfluence.com Rankings
Joseph E. Sokalphysics Degrees
Physics
#5617
World Rank
#7470
Historical Rank
Biophysics
#207
World Rank
#217
Historical Rank
Joseph E. Sokalphilosophy Degrees
Philosophy
#6790
World Rank
#9888
Historical Rank
Logic
#3902
World Rank
#5128
Historical Rank
Download Badge
Physics Philosophy
Joseph E. Sokal's Degrees
- Masters Medicine University of California, San Francisco
- PhD Biophysics University of California, Berkeley
Why Is Joseph E. Sokal Influential?
(Suggest an Edit or Addition)Joseph E. Sokal's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prognostic discrimination in "good-risk" chronic granulocytic leukemia (1984) (664)
- Prognostic discrimination in "good-risk" chronic granulocytic leukemia. (1984) (504)
- Measurement of Delayed Skin-Test Responses (1975) (486)
- Comorbidity of Medical Illnesses Among Adults With Serious Mental Illness Who Are Receiving Community Psychiatric Services (2004) (346)
- Staging and prognosis in chronic myelogenous leukemia. (1988) (212)
- Philadelphia-chromosome-positive and -negative chronic myelocytic leukemia. (1970) (172)
- Effects of cancer chemotherapeutic agents on the human fetus. (1960) (154)
- VARICELLA-ZOSTER INFECTION IN HODGKIN'S DISEASE: CLINICAL AND EPIDEMIOLOGICAL ASPECTS. (1965) (146)
- CLINICAL AND EXPERIMENTAL STUDIES ON FIBRINOLYTIC ENZYMES (1957) (130)
- The delayed skin test response in Hodgkin's disease and lymphosarcoma. Effect of disease activity (1961) (130)
- Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. (1988) (125)
- Whole-blood culture technique for functional studies of lymphocyte reactivity to mitogens, antigens, and homologous lymphocytes. (1973) (123)
- Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. (1985) (122)
- Antagonism Between the Effects of Insulin and Glucagon on the Isolated Liver (1969) (115)
- Lymphocyte response to phytohemagglutinin in Hodgkin's disease. (1970) (112)
- Salmonellosis in disseminated malignant diseases. A seven-- year review (1959-1965). (1967) (110)
- Incidence of malignancy in toxic and nontoxic nodular goiter. (1954) (104)
- Editorial: Measurement of delayed skin-test responses. (1975) (102)
- COMPARISON OF PHILADELPHIA CHROMOSOME-POSITIVE AND-NEGATIVE PATIENTS WITH CHRONIC MYELOCYTIC LEUKEMIA. (1964) (91)
- Evaluation of survival data for chronic myelocytic leukemia (1976) (88)
- RELATIVE POTENCY OF GLUCAGON AND EPINEPHRINE AS HEPATIC GLYCOGENOLYTIC AGENTS: STUDIES WITH THE ISOLATED PERFUSED RAT LIVER. (1964) (81)
- Paraproteinemia in the lymphomas (1966) (77)
- Myeloid leukemia in Hodgkin's disease: chromosomal abnormalities. (1969) (76)
- Complications of BCG vaccination in neoplastic disease. (1975) (73)
- STUDIES OF GLYCOGEN METABOLISM IN LIVER GLYCOGEN DISEASE (VON GIERKE'S DISEASE): SIX CASES WITH SIMILAR METABOLIC ABNORMALITIES AND RESPONSES TO GLUCAGON. (1961) (71)
- Elevation of plasma epinephrine levels produced by glucagon in vivo. (1963) (66)
- Glycogenolytic action of mercaptoethylamine. (1959) (66)
- Glucagon--an essential hormone. (1966) (65)
- Response to bcg vaccination and survival in advanced Hodgkin's disease (1969) (65)
- Delay in progression of malignant lymphoma after BCG vaccination. (1974) (62)
- Suppressive therapy of nontoxic goiter. (1974) (62)
- A Simplified Technique for in Vitro Studies of Lymphocyte Reactivity 1 (1972) (59)
- The problem of malignancy in nodular goiter: recapitulation and a challenge. (1959) (59)
- Preferential inhibition by cytarabine of CFU‐GM from patients with chronic granulocytic leukemia (1987) (52)
- Chromosomes and causation of human cancer and leukemia. XXXIV. A case of “hypereosinophilic syndrome” with unusual cytogenetic findings in a chloroma, terminating in blastic transformation and CNS leukemia (1979) (52)
- Clinical differentiation between thyroid cancer and benign goiter; an evaluation. (1962) (50)
- Comparison of glucagon and epinephrine effects in the dog. (1966) (49)
- Studies in liver glycogen disease. Effects of glucagon and other agents on metabolic pattern and clinical status. (1962) (46)
- Occurrence of thyroid cancer. (1953) (46)
- Long survival in Hodgkin's disease. (1970) (45)
- Effect of glucagon on gluconeogenesis by the isolated perfused rat liver. (1966) (43)
- FANCONI'S ANEMIA AND HEPATIC CIRRHOSIS. (1965) (41)
- Splenectomy for hematologic depression in lymphocytic lymphoma and leukemia (1975) (41)
- Prognosis in chronic myeloid leukaemia: biology of the disease vs. treatment. (1987) (40)
- Evidence for a selective antileukemic effect of cytosine arabinoside in chronic granulocytic leukemia. (1988) (40)
- Basal plasma glucagon levels of man. (1967) (37)
- Removal of abnormal clone of leukaemic cells by splenectomy. (1975) (36)
- Cardiac involvement in lymphosarcoma and reticulum cell sarcoma (1963) (36)
- DIFFERENTIATION OF BENIGN AND MALIGNANT THYROID NODULES BY SCINTISCAN. (1964) (34)
- CARDIAC PROBLEMS IN THE GLYCOGENOSES WITH SPECIFIC REFERENCE TO POMPE'S DISEASE. (1965) (32)
- Prognostic Discrimination in "GoodRisk" Chronic Granulocytic Leukemia (2017) (32)
- Production of Members of the Blood Coagulation and Fibrinolysin Systems by the Isolated Perfused Liver.∗ (1964) (31)
- Splenectomy for palliation of chronic myelocytic leukemia. (1976) (29)
- Treatment of nontoxic goiter with sodium liothyronine. A double-blind study. (1963) (29)
- Glycogen metabolism in the isolated liver. (1958) (29)
- In vitro leukocyte thymidine uptake and prognosis in chronic lymphocytic leukemia. (1979) (28)
- Significance of Ph1-negative marrow cells in Ph1-positive chronic granulocytic leukemia. (1980) (28)
- Liver glycogen disease (von Gierke's disease). (1962) (28)
- Treatment of thrombosis with fibrinolysin (plasmin). (1958) (27)
- Failure of the isolated liver to react to hypoglycemia (1966) (27)
- Sulfapyridine-induced serum-sickness-like syndrome associated with plasmacytosis, lymphocytosis and multiclonal gamma-globulinopathy. (1969) (27)
- Immunotherapy in well-controlled chronic myelocytic leukemia. (1973) (27)
- Controlled study of the treatment of coronary occlusion with urokinase-activated human plasmin (1965) (23)
- Immunologic and biologic properties of antibodies to a glucagon-serum albumin polymer. (1970) (23)
- Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines. (1972) (23)
- Discussion on: Manifestations of Immunologic Unresponsiveness in Hodgkin's Disease (1966) (23)
- Effect of epinephrine on glycogen stores. (1959) (22)
- In vitro leukocyte thymidine uptake in chronic lymphocytic leukemia. (1974) (22)
- UPTAKE OF PLASMA FREE FATTY ACIDS BY THE ISOLATED RAT LIVER: EFFECT OF GLUCAGON. (1963) (22)
- Correlation of delayed hypersensitivity responses with chemotherapeutic results in advanced Hodgkin's disease (1975) (20)
- Circulating colony-forming cells in different stages of chronic myelocytic leukemia. (1979) (20)
- Complete remission in chronic lymphocytic leukemia and leukolymphosarcoma (1967) (20)
- Second neoplasms with chronic lymphocytic leukemia. (1976) (20)
- Spontaneous remission of leukemic lymphoproliferative disease (1971) (20)
- Induction of Tumors by a Virus-Like Agent(s)∗ Released by Tissue Culture (1958) (19)
- Detoxication of thiouracil by S-methylation. (1958) (19)
- The influence of histologic type on the incidence and duration of response in non‐Hodgkin's lymphoma (1982) (19)
- Human leukemia-associated antigens: detection on cells of established lymphoblastoid lines. (1975) (18)
- The Philadelphia chromosome and Philadelphia chromosome mosaicism in chronic granulocytic leukemia. (1986) (18)
- Effect of glucagon on phosphorylase activity of the isolated perfused liver. (1969) (18)
- Effect of glucagon on plasma free fatty acids of normal and pancreatectomized dogs. (1966) (16)
- Effect of high spinal cord section on epinephrine hyperglycemia. (1968) (16)
- Failure of Physiological Concentrations of Epinephrine to affect Glycogen-levels in the Isolated Rat Liver (1964) (15)
- Use of anticancer drugs during pregnancy. (1968) (15)
- Survival of Children with Chronic Myeloid Leukemia (1992) (14)
- Chemotherapy of the terminal phase of chronic myelocytic leukemia with combinations of colchicine derivatives and purine analogs (1978) (14)
- Effects of glucagon and tolbutamide on glycogen in isolated perfused rat liver. (1959) (14)
- Decreased stainable marrow iron in chronic granulocytic leukemia. (1986) (14)
- A long-term follow-up of nontoxic nodular goiter; effect of clinical selection on the observed incidence of malignancy. (1957) (13)
- A colchicine derivative in therapy of chronic myelocytic leukemia. (1961) (13)
- Clonal chromosomal changes in chronic lymphocytic leukemia. (1990) (12)
- Relationship of the adrenal medulla to the hyperglycemic effect of glucagon. (1960) (11)
- EFFECTS OF CANCER CHEMOTHERAPEUTIC AGENTS ON THE HUMAN FETUS (1960) (10)
- Immunotherapy of chronic myelocytic leukemia. (1973) (10)
- Current concepts in the treatment of chronic myelocytic leukemia. (1973) (10)
- Conception and pregnancy in a patient with chronic myelocytic leukemia under continuous colcemide therapy. (1959) (10)
- Relationship of serum total IgE and cell-mediated immunity in patients with Hodgkin's disease. (1977) (10)
- Immunologic Deficiency in Hodgkin's Disease 1 (1973) (9)
- Chronic granulocytic leukemia in a patient with sickle cell anemia. (1988) (9)
- The conversion of cortisone to 17-ketosteroids in patients with carcinoma of the prostate and of the lung. (1959) (9)
- THE DURATION OF GLUCAGON EFFECT1 (1960) (9)
- Failure of Blood Glucose Levels to Reflect Hepatic Glycogenolysis; Experiences with Glucagon.∗ (1958) (8)
- In vitro thymidine uptake by circulating leukocytes. (1974) (8)
- Liver lipid as a source of embolic fat. (1961) (7)
- Immunotherapy of Myeloid Leukemia. (1972) (7)
- LIVER GLYCOGEN DISEASE IN TWO GENERATIONS OF A FAMILY. CLINICAL STUDIES AND TISSUE ANALYSES DURING OVERT DISEASE AND AFTER APPARENT RECOVERY. (1964) (6)
- Cellular immune responses and prognosis in malignant lymphomas. (1971) (6)
- Malignant Tumours of the Thyroid Gland (1968) (6)
- Failure of Diazoxide to Affect Carbohydrate Metabolism of the Isolated Liver (1968) (6)
- Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy (1973) (5)
- Clinical experience with a new alkylating agent AB-132, in the treatment of lymphomas and leukemias. (1962) (5)
- The effect of cortisone and cortisol on 17‐ketosteroid excretion in carcinoma of the prostate and other neoplasms (1959) (5)
- Glucose-6-phosphate leveps and liver glycogen disease. (1962) (5)
- Low dose ara-C administered by continuous subcutaneous infusion: a pharmacologic evaluation. (1986) (5)
- Immunization with Cultured Cell-BCG Mixtures (1974) (5)
- The serological detection of leukemia‐associated antigens in chronic leukemia: Correlation with disease status (1977) (5)
- "Antigenic" disparity between cultured lymphoid cells and autologous lymphocytes. (1972) (4)
- Bioassay of glucagon using the isolated perfused rat liver. (1970) (4)
- Survival in Ph1-positive chronic myelocytic leukemia: relationship to findings at diagnosis and to disease kinetics after the first course of treatment. (1985) (4)
- Panel discussion: the evaluation of clot-lysing agents in the treatment of thrombotic disease. (1960) (4)
- The colony-forming cell in the normal and leukemia human host: responses to streptovaricin and rifamycin SV. (1974) (4)
- Leukocyte (3H) thymidine uptake in short-term whole-blood cultures of human and canine renal allograft recipients. (1973) (4)
- Progress report on immunotherapy of chronic myeloid leukemia. (1978) (3)
- Cholestatic jaundice in association with desacetylmethylcolchicine; report of a case. (1959) (3)
- Immunotherapy for chronic granulocytic leukaemia. (1977) (3)
- Thymidine uptake by circulating leukocytes in chronic myelocytic leukemia before and after therapeutic splenectomy. (1980) (3)
- Clinical and experimental pharmacology of parenteral spiramycin (1962) (3)
- Hepatic glycogenolysis induced by glucagon in a patient with type I liver glycogen disease. (1970) (3)
- The Real World Guide to Psychotherapy Practice. (2001) (2)
- Prognostic value of serial measurements of leukocyte thymidine uptake in well-controlled chronic myelocytic leukemia. (1981) (2)
- Immunotherapy with cultured human cells and BCG. (1975) (2)
- Surgical statistics on malignant goiter. (1954) (2)
- Clinical evaluation of AB-132 in the management of advanced bronchogenic carcinoma. (1962) (2)
- An unusual neurologic syndrome in Hodgkin's disease. (1956) (2)
- Thymic irradiation and chronic myelogenous leukemia. (1977) (1)
- A glycogenolytic factor. I. Effect of liver extract on glycogen stores of rats. (1952) (1)
- Definition of Chronic Myelocytic Leukemia (CML) According to the Ph1 Chromosome. (1969) (1)
- Liver Glycogen Disease in Two Generations of a Family* Clinical Studies and Tissue Analyses During Apparent Recovery (1964) (1)
- [Evaluation of 196 patients with chronic myeloid leukemia based on a standard prognosis model]. (1990) (1)
- SYSTEMIC AND LOCAL ANTITUMOR EFFECT OF THE ANTIBIOTIC SPIRAMYCIN: A PHARMACOLOGIC AND CLINICAL STUDY. (1964) (1)
- Experiences with cortisone in management of far-advanced carcinoma of prostate. (1954) (0)
- Comparison of L-Thyroxine (T4) and L-Triiodothyrone (T8) in Suppressive Therapy of Nontoxic Nodular Goiter. (1971) (0)
- The Physiologic Function of Glucagon. (1966) (0)
- How dangerous are thyroid nodules? 1955. (2005) (0)
- Clinical and laboratory studies on the fibrinolysin system and is therapeutic use. (1960) (0)
- Evaluation of Cyren-B as a Leukocyte Protecting Agent in Patients Undergoing Radiotherapy or Chemotherapy for Malignant Lymphoma (1961) (0)
- Use of vinblastine in the terminal phase of chronic myelocytic leukemia. (1979) (0)
- The Synthesis of Protein-Azobenzyl-Nucleic Acid Compounds * (1953) (0)
- Effect of Cortisone on 17-Ketosteroid Excretion * (1954) (0)
- Treatment of intolerance to quinacrine. (1950) (0)
- An Immunologic Test for Prognosis in Advanced Hodgkin's Disease. (1969) (0)
- Human liver glycogen levels. (1959) (0)
- Contents, Vol. 55, 1977 (1977) (0)
- The effect of cortisone on 17-ketosteroid excretion of patients with carcinoma of the prostate. (1954) (0)
- New developments in cancer (1956) (0)
- AB-103, a new chemotherapeutic agent in the treatment of bronchogenic carcinoma-a preliminary report. (1960) (0)
- How dangerous are thyroid nodules? (1955) (0)
- Immunotherapy of lung cancer with Corynebacterium parvum (1979) (0)
- A phase I clinical study of a serological test for detection of leukemia-associated antigens (LAA) (1978) (0)
- Malignant Tumours of the Thyroid Gland: Edith Beregi, R. Jankovics, and Z. Brasch. Budapest: Adadémiai Kiadó, 1967. 81 pp. $6. (1968) (0)
- Evaluation of Cyren-B as a leukocyte protecting agent in patients undergoing radiotherapy or chemotherapy for malignant lymphoma. (1961) (0)
- Role of the liver in the regulation and maintenance of the blood glucose level. (1960) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Joseph E. Sokal?
Joseph E. Sokal is affiliated with the following schools:
